• LAST PRICE
    2.1900
  • TODAY'S CHANGE (%)
    Trending Down-0.1400 (-6.0086%)
  • Bid / Lots
    2.2000/ 16
  • Ask / Lots
    2.2900/ 7
  • Open / Previous Close
    2.2700 / 2.3300
  • Day Range
    Low 2.1800
    High 2.3400
  • 52 Week Range
    Low 1.3500
    High 15.3400
  • Volume
    378,771
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 2.33
TimeVolumeTSHA
09:32 ET81402.26
09:33 ET13002.29
09:35 ET23002.335
09:39 ET14002.33
09:42 ET76472.28
09:44 ET23052.3
09:48 ET3002.28
09:50 ET47062.28
09:51 ET70982.28
09:53 ET94092.27
09:55 ET44812.23
09:57 ET113152.24
10:00 ET2002.24
10:02 ET1002.245
10:04 ET3002.245
10:06 ET7002.22
10:08 ET65542.22
10:09 ET55412.2
10:11 ET2002.19
10:13 ET28792.2234
10:15 ET93572.215
10:18 ET4002.2178
10:20 ET3002.2272
10:22 ET22932.22
10:24 ET4002.2
10:26 ET19002.19
10:27 ET6602.19
10:29 ET10002.215
10:31 ET20002.21
10:33 ET1002.235
10:36 ET3332.2334
10:40 ET1002.21
10:42 ET2002.21
10:44 ET1002.22
10:47 ET1002.22
10:49 ET2002.21
10:51 ET2002.2256
10:54 ET1002.21
10:56 ET3002.21
10:58 ET22742.2133
11:00 ET7552.2199
11:02 ET64702.23
11:03 ET10002.23
11:05 ET23032.24
11:09 ET4002.24
11:12 ET105732.24
11:14 ET29112.245
11:16 ET2012.24
11:18 ET3002.225
11:20 ET2092.2205
11:21 ET10352.2235
11:23 ET2002.22
11:25 ET22902.2299
11:27 ET6002.23
11:32 ET8002.235
11:34 ET5722.23
11:36 ET2002.23
11:38 ET1002.22
11:39 ET1002.22
11:45 ET5002.22
11:48 ET34002.22
11:50 ET25002.215
11:52 ET4222.23
11:56 ET2002.22
11:59 ET1002.235
12:01 ET28002.23
12:03 ET1002.22
12:06 ET4002.22
12:12 ET1002.22
12:14 ET6392.2111
12:15 ET5802.21
12:17 ET27632.2101
12:19 ET5302.21
12:21 ET10002.22
12:26 ET23902.22
12:32 ET14192.225
12:35 ET4002.23
12:44 ET21632.23
12:51 ET2002.22
12:53 ET2002.22
12:55 ET534082.2
12:57 ET12252.19
01:00 ET19002.2
01:04 ET4002.21
01:06 ET1002.21
01:09 ET3002.2
01:11 ET1602.2
01:13 ET1002.21
01:15 ET16462.2133
01:20 ET4222.2
01:22 ET1002.21
01:24 ET5002.21
01:26 ET2002.2
01:31 ET5902.2
01:33 ET2122.215
01:38 ET28002.215
01:42 ET94172.2
01:47 ET2002.19
01:49 ET11002.19
01:51 ET2002.2035
01:54 ET1002.2
02:00 ET2502.19
02:02 ET3002.2
02:03 ET66042.19
02:05 ET8002.19
02:09 ET1002.18
02:12 ET40912.2
02:14 ET50002.2
02:16 ET7722.21
02:18 ET1002.1901
02:21 ET10502.205
02:23 ET10752.21
02:25 ET2002.21
02:27 ET2002.21
02:30 ET25912.23
02:32 ET26972.23
02:34 ET1002.23
02:36 ET2502.2264
02:43 ET20002.22
02:45 ET8302.23
02:50 ET1002.23
02:52 ET18502.23
02:54 ET1002.22
02:56 ET1002.21
02:57 ET2602.21
02:59 ET2502.21
03:01 ET2002.21
03:06 ET8002.22
03:12 ET13002.21
03:14 ET4272.2
03:15 ET1002.2
03:17 ET1002.2
03:19 ET2002.19
03:21 ET36002.215
03:26 ET5002.2216
03:28 ET52372.21
03:33 ET82692.215
03:35 ET2002.215
03:37 ET25002.215
03:39 ET32002.215
03:42 ET2002.215
03:44 ET81012.25
03:46 ET76622.25
03:48 ET15312.24
03:50 ET8002.24
03:51 ET11742.21
03:53 ET104502.21
03:55 ET10002.23
03:57 ET13402.2
04:00 ET148102.19
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTSHA
Taysha Gene Therapies Inc
145.5M
-0.5x
---
United StatesOMIC
Singular Genomics Systems Inc
148.5M
-1.6x
---
United StatesMTNB
Matinas BioPharma Holdings Inc
149.6M
-6.1x
---
United StatesEPIX
ESSA Pharma Inc
141.0M
-3.8x
---
United StatesVBIV
VBI Vaccines Inc
149.3M
-1.4x
---
United StatesCELC
Celcuity Inc
139.1M
-3.9x
---
As of 2022-11-28

Company Information

Taysha Gene Therapies, Inc. is a patient-centric gene therapy company. The Company is focused on developing and commercializing adeno-associated virus (AAV)-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS). Its portfolio of gene therapy candidates targets a range of neurological indications across three distinct therapeutic categories: neurodegenerative diseases, neurodevelopmental disorders and genetic epilepsies. Its product candidates include TSHA-101, which is being developed for the treatment of giant axonal neuropathy (GAN); TSHA-102, a neurodevelopmental disorder product candidate, which is being developed for the treatment of Rett syndrome; TSHA-118, which is a AAV9 viral vector that expresses human codon-optimized Ceroid Lipofuscinosis Neuronal 1 complementary deoxyribonucleic acid under control of the chicken b-actin hybrid promoter, and TSHA-105, a gene replacement therapy for the treatment of SLC13A5 deficiency.

Contact Information

Headquarters
3000 Pegasus Park Drive, Suite 1430DALLAS, TX, United States 75247
Phone
214-612-0000
Fax
---

Executives

Independent Chairman of the Board
Sean Nolan
President, Chief Executive Officer, Director
Ra Session
Chief Financial Officer
Kamran Alam
Chief Medical Officer, Head of Research and Development
Suyash Prasad
Independent Director
Phillip Donenberg

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$145.5M
Revenue (TTM)
$0.00
Shares Outstanding
62.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-4.12
Book Value
$2.48
P/E Ratio
-0.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.